Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Paragon Care Limited ( (AU:PGC) ) has shared an announcement.
Paragon Care Limited has disclosed a change in director David Collins’ indirect interest in the company, with Collins acquiring an additional 2,000,000 ordinary shares via an on‑market trade on 30 December 2025 at $0.2192 per share. The purchase, made through the Collins Millar Family account where Collins is a discretionary beneficiary, lifts his indirect holding to 477,507,317 ordinary shares, signalling a further alignment of the director’s financial interests with those of shareholders and underscoring confidence in the company’s prospects.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.20 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-listed company that supplies medical equipment, devices and healthcare solutions to hospitals, clinics and allied health providers. The group focuses on serving the healthcare market through the distribution and servicing of specialised medical products and technologies across Australia and neighbouring regions.
YTD Price Performance: 2.33%
Average Trading Volume: 984,518
Technical Sentiment Signal: Sell
Current Market Cap: A$364.2M
For an in-depth examination of PGC stock, go to TipRanks’ Overview page.